{
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 112,
    "total_characters": 26849
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 4,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "5. Treanor JJ, Schiff GM, Hayden FG, et al. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA. 2007 Vol. 297, pp. 1577-1582.",
      "relevance_explanation": "This reference is cited in the context of clinical studies comparing the immunogenicity of recombinant hemagglutinin (rHA) vaccines (such as Flublok, a higher-dose recombinant flu vaccine) to standard egg-based vaccines, directly supporting the claim that recombinant vaccines may induce a more robust antibody response."
    },
    {
      "id": 2,
      "quote": "3. Keitel WA, Treanor JJ, El Sahly HM, et al. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccines (TIVs) among persons \u226565 years old. Vaccine 2009 Vol. 28, pp. 379\u2013385.",
      "relevance_explanation": "This reference is cited as a comparative study of the immunogenicity of recombinant (higher-dose) and standard egg-based influenza vaccines in older adults, supporting the claim that the recombinant vaccine may induce a more robust antibody response."
    },
    {
      "id": 3,
      "quote": "For the 2024-2025 influenza season it is formulated to contain 135 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 3 influenza virus strains... Flublok contains no egg proteins, antibiotics, or preservatives.",
      "relevance_explanation": "This statement establishes that Flublok is a higher-dose recombinant flu vaccine (135 mcg total HA per dose) and is not egg-based, which is necessary context for understanding the basis of its potentially more robust antibody response compared to standard-dose, egg-based vaccines."
    },
    {
      "id": 4,
      "quote": "Flublok\u00ae versus licensed inactivated influenza vaccine in healthy, medically stable adults \u226550 years of age. Vaccine. 2015, Vol. 33, pp. 6622-6628.",
      "relevance_explanation": "This reference is cited in the context of clinical studies comparing Flublok (a higher-dose recombinant vaccine) to standard egg-based vaccines, supporting the claim that Flublok may induce a more robust antibody response."
    }
  ],
  "model_used": "gpt-4.1"
}